Building CRISPR Immunity Systems - How is Invading DNA Captured?
Building CRISPR Immunity Systems - How is Invading DNA Captured?
批准号:
BB/T006625/1
负责人:
Edward Bolt
金额:
$45.8万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CRISPR systems have evolved in microbes to give them immunity against death or unwanted genetic baggage from viruses and other mobile genetic elements (MGEs). The immunity system is built when fragments of MGE DNA are recognised, captured and stored in the microbe's CRISPR system - these processes are called "adaptation". Once stored, the MGE DNA fragments in CRISPR are converted into RNA by transcription, and the CRISPR RNA is used to seek and destroy returning MGE DNA, therefore protecting the microbial cell from re-infection and death. Some parts of the processes that control CRISPR-based adaptation are known, however it is unknown how viral DNA/RNA is recognised as "non-self" and is therefore captured to establish immunity the first time it is encountered by the microbe. We know that Cas1-Cas2 enzyme complex is essential for CRISPR adaptation, but we do not know fully how adaptation is achieved either in natural cellular systems or in the molecular detail of individual genes and proteins. We will investigate the cell and molecular biology of the Cas1-Cas2 enzyme complex to understand how it can capture fragments of virus DNA. This will be performed using E. coli as a model bacterium, examining the biochemistry of DNA capture, the genetic components that are vital parts of the process and using time lapse microscopic imaging of live cells to observe adaptation in real time and in unprecedented detail. The new knowledge of how CRISPR immunity develops in bacteria is important for many different areas of biology, from microbiology and antibacterial resistance, DNA breaks and genome instability to the biotechnology applications of genetic engineering.Understanding how immunity is generated in bacteria is important for microbiologists who are interested in antibiotic resistance as this is a challenge that urgently needs to be overcome. By knowing how CRISPR immunity functions in normal healthy bacteria will enable the development of natural strategies to overcome antibiotic resistance where the resistance genes are often carried on genetic elements that are destroyed by CRISPR.Our new methods for imaging of Cas1 in cells will also benefit researchers interested in understanding genome dynamics in cells, specifically how and why DNA gets broken. This is directly relevant to biologists who wish to understand how genome instability arises and leads to the problems manifested in various human diseases such as cancer, and the ageing process. CRISPR is widely used as biotechnology tool genetic engineering and editing in cells, but the Cas1-Cas2 complex is not as well developed as other CRISPR-based genetic editing methods e.g. Cas9. Understanding how Cas1-Cas2 can capture DNA molecules before storing them in a DNA fragment database e.g. CRISPR has potential to streamline its use as an editing tool in many applications.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1042/bsr20203595
发表时间:
2021-01-29
期刊:
Bioscience reports
影响因子:
4
作者:
[Lau CH, Bolt EL]
通讯作者:
Bolt EL
DOI:
10.1093/nar/gkad032
发表时间:
2023-02-28
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[]
通讯作者:
DOI:
10.1042/bsr20221198
发表时间:
2023-03-31
期刊:
Bioscience reports
影响因子:
4
作者:
[]
通讯作者:
DOI:
10.3390/ijms22062848
发表时间:
2021-03-11
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[He L, Matošević ZJ, Mitić D, Markulin D, Killelea T, Matković M, Bertoša B, Ivančić-Baće I, Bolt EL]
通讯作者:
Bolt EL
CRISPR Adaptation - the basis for prokaryotic adaptive immunity
-
批准号:BB/M020541/1
-
项目类别:Research Grant
-
资助金额:$41.88万
-
财政年份:2015
-
负责人:Edward Bolt
-
依托单位:
国内基金
海外基金
登录
查看更多内容
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
CRISPR驱动的自维持催化核酸网络用于AFB1的高保真检测
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李香芝
-
依托单位:
介入输注CRISPR-Cas9 构建的 SHP-1-KO T 细胞联合靶向肝癌细胞脂质代谢通路的协同抗肝癌机制研究
-
批准号:2026JJ50324
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘华平
-
依托单位:
基于 CRISPR/Cas13a 与熵驱动反应的多级信号放大电化学传感平台在胰腺炎复发标志物联合检测中的应用研究
-
批准号:ZCLKLY26H2003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王旭耀
-
依托单位:
等温扩增联合CRISPR/Cas12a系统在疱疹病毒性脑炎精准诊断中的应用研究
-
批准号:2026JJ82346
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陆玉颖
-
依托单位:
全基因组CRISPR/Cas9文库筛选发现IGF1R通过抑制细胞焦亡途径诱导结直肠癌奥沙利铂耐药的机制研究
-
批准号:2026JJ80578
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨熙华
-
依托单位:
CRISPR/Cas9精确编辑NOTCH2NLC基因GGC重复扩增突变的治疗策略探究
-
批准号:2026JJ50082
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢妮娜
-
依托单位:
利用CRISPR/Cas9和单细胞多组学技术探索IRF-1介导代谢重编程在肝缺血再灌注损伤后肝脏再生中的作用机制
-
批准号:2026JJ50622
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗静
-
依托单位:
海南石斑鱼苗种弧菌CRISPR光电快速诊断技术及智能检疫装备研发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨治庆
-
依托单位:
基于MOF–CRISPR微流控平台的雄黄As(III)/As(V)价态识别与炮制耦合机制研究
-
批准号:JCZRLH202600780
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: